Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022
Surgalign Spine Technologies (NASDAQ: SRGA) will release its Q1 2022 financial results after market close on May 10, 2022. The company will host a conference call at 4:30 p.m. ET on the same day, accessible by phone or via a webcast on their investor website. Surgalign focuses on advancing digital surgery and markets its products in over 50 countries. The company emphasizes its commitment to delivering superior clinical outcomes and transforming the surgical landscape through innovative technologies.
- Surgalign markets products in over 50 countries, expanding its reach.
- The company focuses on digital health to enhance surgical outcomes.
- None.
DEERFIELD, Ill., April 26, 2022 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced it plans to release financial results from the first quarter 2022 after the close of trading on May 10th, 2022.
Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604-1616 (U.S.) or (201) 689-8043 (International). The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for one month following the call.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Investor and Media Contact:
Mike Vallie
IR@surgalign.com
+1 443 213 0499
Surgalign Contact:
Kristine Simmons
ksimmons@surgalign.com
+1 619 206 4648
FAQ
When will Surgalign announce its Q1 2022 financial results?
What time is the Surgalign conference call related to Q1 2022 results?
How can I access the Surgalign Q1 2022 earnings call?
